Versant Capital Management »

Takeda Pharmaceutical shares owned by Versant Capital Management

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $396k 27k 14.64
2025-06-30 $386k 25k 15.46
2025-03-31 $374k 25k 14.87
2024-12-31 $26k 2.0k 13.24
2019-03-31 $0 0 0.00

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Microsoft Stock (MSFT)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Ishares S&p Global Energy Etf (IXC)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Nvidia Corp Stock (NVDA)
Apple Stock (AAPL)
Vanguard Total Stk Mkt Etf (VTI)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)

View all positions for Versant Capital Management

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Morgan Stanley
UBS Group
Goldman Sachs Group
FMR
Brandes Investment Partners
Renaissance Technologies
BlackRock
Toronto-Dominion Bank
Arrowstreet Capital, Limited Partnership
Millennium Management
First Trust Advisors
Northern Trust
Qube Research & Technologies
Citadel Advisors

View all funds holding Takeda Pharmaceutical